top of page
Founder and Chairperson Peter Loeffelhardt created a series of video clips with a focus on hearing the perspectives of the MPN community. The videos represent the 3Ps: Patients, Physicians
Top 10 Facts that Patients with Myeloproliferative Neoplasms Need to Know About Pacritinib (Vonjo)
Executive Director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and MPN-focused Clinician Investigator, Ruben A. Mesa, MD, discusses the Top 10 Facts that Patients with Myeloproliferative Neoplasms (especially those with myelofibrosis) Need to Know About the FDA Approval of Pacritinib (Vonjo). Follow Dr. Ruben Mesa on Twitter @mpdrc. For more updates from the Mays Cancer Center, follow us on Facebook and Instagram @UTHealthSAMDAnderson and Twitter @UTHealthSAMDA.
10 facts MPN patients need to know about FDA approval of Ropegylated interferon alpha2b (Besremi).
Ruben Mesa, MD, FACP, executive director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, and MPN expert and investigator, discusses the top 10 facts that patients with myeloproliferative neoplasms (especially those with polycythemia vera) need to know about the FDA approval of Ropegylated interferon alpha2b (Besremi). Follow Dr. Mesa on Twitter @mpdrc. Visit cancer.uthscsa.edu to learn more about the Mays Cancer Center. Follow Mays Cancer Center on social media. Facebook: UTHealthsaMDAnderson Instagram: UTHealthsaMDAnderson Twitter: @UTHealthSAMDA
Peter&Friends—Marking MPN Awareness Day — Industry Perspective: Infusing the patient voice is key
Pleasure to speak with Samit Hirawat, Executive Vice President, Chief Medical Officer at Bristol Myers Squibb. He discusses the importance of MPN patients being treated with urgency, and provides hope to patients as scientists and the industry work tirelessly to identify new medicines to bring forward in the treatment of MPNs. It is great to hear the commitments being made to infuse the patient voice in every step of the drug development journey.
Peter&Friends—Marking MPN Awareness Day — Physician Perspective: The evolving treatment landscape
To continue the Peter&Friends video series, I had a great chat with Srdan Verstovsek of MD Anderson Cancer Center, Houston, US. He discusses the advancement of science and the evolving MPN treatment landscape, offering hope to those living with MPNs. An important message to mark MPN Awareness Day.
Peter&Friends—Marking MPN Awareness Day — Patient Advocate Perspective: How to drive awareness
I caught up with good friend and advocate Andrew Schorr of Patient Power to continue the Peter&Friends video series. An empowered person living with MPNs can certainly be the catalyst in the shared decision-making decision with their health care provider.
bottom of page